• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    Merck KGaA, Quris-AI Expand Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC

    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    Lannett CDMO

    Bachem

    AMERIPHARMA

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    Lannett CDMO

    Bachem

    AMERIPHARMA

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Sterile Manufacturing Trends & Overcoming Challenges

    Sterile biologics R&D, new delivery platforms for complex APIs, and single use technologies drive outsourcing.

    Sterile Manufacturing Trends & Overcoming Challenges
    Kristin Brooks, Managing Editor, Contract Pharma09.08.22
    Many complex drug products require sterile capabilities leading to increased demand for aseptic manufacturing. Aseptic processing is uniquely challenging as it requires highly trained personnel and specialized facilities and equipment. The FDA requires that drug products delivered via parenteral, ophthalmic, inhaled, or otic route be supplied as sterile products due to increased risk of infection. As these complex formulations become more common, there is an increased need for sterile manufacturing operations, resulting in outsourcing to contract manufacturers. 

    According to a new report by Visiongain: Global Biopharmaceuticals Contract Manufacturing Market Forecast 2022-2032: Market Segment by Source, Service, Product, Company Size, Scale of Operations, By Region, the market was estimated to be valued at $12.9 billion in 2021. The worldwide market is expected to witness a CAGR of 8.53% from 2022 to 2027 and is expected to reach $21.0 billion in 2027 from its previous value of $13.96 billion in 2022. 

    According to Visiongain analysis, the biopharmaceutical market's success is primarily due to contract manufacturers, as CMOs can provide advantages such as reduced total investment necessary to bring products to market, access to advanced technology, and faster product entrance into markets, as well as more flexibility, prompting sponsors to outsource their biopharmaceutical manufacture. Additionally, as the biopharmaceutical business continues to grow, organizations are encountering production challenges, such as a lack of experience and advanced equipment, while performing in-house manufacturing, according to the report. 

    Catalent’s Paresh Vadgama, Principal Scientist, Biologics Formulation and Drug Product Development, and Dhaval Patel, Director, Manufacturing Science and Technology, address sterile manufacturing trends, current challenges pharmaceutical companies face, and advances in sterile manufacturing processes. –KB 

    Contract Pharma: What are some sterile manufacturing trends and/or R&D trends impacting sterile manufacturing?

    Paresh Vadgama: Three areas within sterile biologics R&D are currently seeing rapid growth: next-generation antibody development (e.g., antibody-drug conjugates, bi/tri-specific antibodies); new delivery platforms for complex APIs, such as lipid nanoparticles for mRNAs; and of the switching of drug product delivery methods. These, as well as overcoming molecular instability, extreme solution characteristics such as high-viscosity, and the need for preserving sterility during manufacturing (as opposed to terminal sterilization that is not an option for temperature-sensitive formulations), limit the choice of compatible bioprocessing raw materials. 

    In manufacturing, the use of end-to-end single use technologies is increasing, allowing shorter timelines by eliminating laborious and costly validation work, as well as reducing product changeover time. In addition, Catalent is seeing growth in the need to process temperature-sensitive products, which need to be stored and delivered using energy-efficient supply chain solutions, as well as the development of novel, safer and stable excipients and potentially re-purposing previously approved, generally recognized as safe (GRAS)-listed excipients for novel biologics.

    Contract Pharma: What are some current sterile manufacturing challenges the industry or pharma companies face?

    Dhaval Patel: The pandemic changed the way the pharmaceutical industry operated, and its effects are still being felt today. For example, the supply chain is still heavily constrained by longer lead times for critical excipients, components, and consumables that are necessary for manufacturing. Because of this, sponsor companies are looking to diversify their supply chains with a growing reliance on outsourcing partners. As sponsors identify additional partners, there is pressure for these to assist in reducing time to market. In some scenarios, critical resources, whether a process or a material, can be rate-limiting, but the work that was undertaken during the pandemic demonstrated that the pharmaceutical industry can safely accelerate products to patients when it works collaboratively to find and implement creative solutions. 

    Contract Pharma: How can the above manufacturing challenges be overcome? Are there any advances in sterile manufacturing processes to combat those challenges?

    Dhaval Patel: As sponsor companies continue to outsource, it is important that they keep three factors in mind: efficiency, technology, and experience. An outsourcing partner should have proven sterile manufacturing experience, and be able to demonstrate how its track record has helped take a product from clinic to multiple global markets. That experience could include working on numerous programs, and being able to streamline processes while standardizing equipment to pass on efficiencies to sponsor companies. Some technologies that outsourcing partners may offer could be new to sponsors, so it is important to highlight any advantages that could ultimately mean that a product reaches patients faster.
     

    Dhaval Patel is Director, Manufacturing Science and Technology (MS&T) for Catalent Biologics and has over 12 years of experience in the pharmaceutical industry and biologics space. Mr. Patel leads a large team of MS&T scientists and engineers, and is responsible for the technical transfer of manufacturing processes at Catalent Biologics’ facility in Bloomington, Indiana. Previously, he was a scientist in MS&T for Cook Pharmica, a company acquired by Catalent. He holds a master’s degree in pharmaceutical engineering from Stevens Institute of Engineering.


    Paresh Vadgama has over 14 years of experience in biological drug product development. In his current role as Principal Scientist, Biologics Formulation & Drug Product Development at Catalent he leads cross-functional efforts in the areas of formulation, process, primary packaging development, and tech-transfer practices across the U.S. and European biologics sites. He holds a master’s degree in pharmaceutical sciences with specialization in drug delivery from the Institute of Chemical Technology (formerly, UDCT), India.
    Related Searches
    • Biologics, Proteins, Vaccines
      Loading, Please Wait..
      Breaking News
      • Univercells Expands into the U.S. With New Offices in Andover, MA
      • Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
      • Sanner Group Opens Second Manufacturing Facility in China
      • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
      • Merck KGaA, Quris-AI Expand Collaboration
      View Breaking News >
      CURRENT ISSUE

      September 2023

      • Pharma Supply Chains: From Fragile to Agile
      • Overcoming Stressors in Knowledge Transfer
      • Innovations in Pharma Packaging
      • HPAPI Manufacturing Trends
      • Sustainable Packaging in Pharma: No Longer a Pipe Dream
      • Revolutionizing Pharma’s Supply Chain
      • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
      • Solving Pharma’s Underlying Rebate Leakage Problem
      • Advanced Manufacturing and a Roadmap to the Facility of the Future
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
      Natrol Launches First Non-Melatonin Sleep Supplement
      Metagenics Releases Consumer Survey on Menopausal Support Supplement
      Coatings World

      Latest Breaking News From Coatings World

      California Sports Surfaces Celebrates 70 Years
      ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
      AkzoNobel Shares Sustainable Architectural Solutions at Conference
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
      SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
      ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Univercells Expands into the U.S. With New Offices in Andover, MA
      Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
      Sanner Group Opens Second Manufacturing Facility in China
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
      74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
      Stoelzle Glass Group Names New CEO
      Happi

      Latest Breaking News From Happi

      The Estée Lauder Companies Launches 2023 Breast Cancer Campaign
      BASF Personal Care Introduces New Cosmetic Ingredient
      Breakfast with Oral Care Benefits?
      Ink World

      Latest Breaking News From Ink World

      Siegwerk’s Climate Targets Validated by SBTi
      ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
      Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      SABIC and partners launch bio-based IML solution for food packaging
      tesa completes expansion of Michigan manufacturing facility
      Comexi and Asahi to host 'Effortless Platemaking' event
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Greentech Introduces Air Filter with Advanced Odor Elimination
      Ontex Divests Pakistan Operations to ASAIA Holding
      Goodnites Bedwetting Underwear Recognized by Good Housekeeping
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
      ChitogenX Granted New U.S., Canadian ORTHO-R Patent
      Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
      Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
      SCHOTT Strengthens Glass Substrate Portfolio

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login